Literature DB >> 4300089

Sensitivity of herpes simplex virus, vaccinia virus, and adenoviruses to deoxyribonucleic acid inhibitors and thiosemicarbazones in a plaque suppression test.

E C Herrmann.   

Abstract

Herpes simplex and vaccinia viruses and adenovirus types 1, 2, 5, and 7 were tested by plaque suppression methods for sensitivity to halogenated deoxyuridines (5-iodo-, 5-bromo-, 5-chloro-, and 5-fluoro-), cytosine arabinoside, isatin-beta-thiosemicarbazone, and N-methylisatin-beta-thiosemicarbazone. After incubation for 12 days in HeLa cell cultures, vaccinia virus plaques were still readily suppressed by deoxyribonucleic acid (DNA) inhibitors and thiosemicarbazones. Herpes simplex virus plaques were likewise suppressed by at least three DNA inhibitors. Adenovirus plaques were not suppressed by DNA inhibitors or thiosemicarbazones. 5-Fluoro-2'-deoxyuridine could not be shown to have any antiviral activity, but it did produce a substantial lethal action on the cells.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 4300089      PMCID: PMC547611          DOI: 10.1128/am.16.8.1151-1155.1968

Source DB:  PubMed          Journal:  Appl Microbiol        ISSN: 0003-6919


  16 in total

1.  SOME BIOLOGIC ASPECTS OF HERPESVIRUS-CELL INTERACTIONS IN THE PRESENCE OF 5-IODO, 2-DESOXYURIDINE (IDU). DEMONSTRATION OF A CYTOTOXIC EFFECT BY HERPESVIRUS.

Authors:  K O SMITH
Journal:  J Immunol       Date:  1963-11       Impact factor: 5.422

2.  CELL CULTURE STUDIES ON ANTIVIRAL AGENTS. I. ACTION OF CYTOSINE ARABINOSIDE AND SOME COMPARISONS WITH 5-IODO-2-DEOXYURIDINE.

Authors:  D A BUTHALA
Journal:  Proc Soc Exp Biol Med       Date:  1964-01

3.  Comparison of specific antiviral agents in herpes simplex keratitis.

Authors:  H E KAUFMAN; E D MALONEY; A B NESBURN
Journal:  Invest Ophthalmol       Date:  1962-10

4.  Plaque inhibition test for detection of specific inhibitors of DNA containing viruses.

Authors:  E C HERRMAN
Journal:  Proc Soc Exp Biol Med       Date:  1961-05

5.  Effect of 5-halogenated pyrimidines on cell proliferation and adenovirus multiplication.

Authors:  L KJELLEN
Journal:  Virology       Date:  1962-09       Impact factor: 3.616

6.  Agar diffusion method for detection and bioassay of antiviral antibiotics.

Authors:  E C HERRMANN; J GABLIKS; C ENGLE; P L PERLMAN
Journal:  Proc Soc Exp Biol Med       Date:  1960-03

7.  ANTI-HERPETIC ACTIVITY OF 5-IODO-2'-DEOXYURIDINE IN PRESENCE OF ITS DEGRADATION PRODUCTS.

Authors:  C G ENGLE; R C STEWART
Journal:  Proc Soc Exp Biol Med       Date:  1964-01

Review 8.  Problems in virus chemotherapy.

Authors:  H E Kaufman
Journal:  Prog Med Virol       Date:  1965

9.  Inhibition of adenovirus replication by 1-beta-D-arabinofuranosylcytosine.

Authors:  L A Feldman; F Rapp
Journal:  Proc Soc Exp Biol Med       Date:  1966-05

10.  Adenovirus multiplication: inhibition by methisazone.

Authors:  D J Bauer; K Apostolov
Journal:  Science       Date:  1966-11-11       Impact factor: 47.728

View more
  4 in total

1.  Sensitivity of Types 1 and 2 Herpes Simplex Virus to 5-Iodo-2'-Deoxyuridine and 9-beta-d-Arabinofuranosyladenine.

Authors:  D A Person; P J Sheridan; E C Herrmann
Journal:  Infect Immun       Date:  1970-12       Impact factor: 3.441

2.  New class of orthopoxvirus antiviral drugs that block viral maturation.

Authors:  Chelsea M Byrd; Tové C Bolken; Adnan M Mjalli; Murty N Arimilli; Robert C Andrews; Robert Rothlein; Tariq Andrea; Mohan Rao; Katrina L Owens; Dennis E Hruby
Journal:  J Virol       Date:  2004-11       Impact factor: 6.549

3.  Inhibition of Chikungunya Virus Replication by 1-[(2-Methylbenzimidazol-1-yl) Methyl]-2-Oxo-Indolin-3-ylidene] Amino] Thiourea(MBZM-N-IBT).

Authors:  Priyadarsee Mishra; Abhishek Kumar; Prabhudutta Mamidi; Sameer Kumar; Itishree Basantray; Tanuja Saswat; Indrani Das; Tapas Kumar Nayak; Subhasis Chattopadhyay; Bharat Bhusan Subudhi; Soma Chattopadhyay
Journal:  Sci Rep       Date:  2016-02-04       Impact factor: 4.379

Review 4.  Diagnosis of viral disease and the advent of antiviral drugs.

Authors:  E C Herrmann; J A Herrmann
Journal:  Pharmacol Ther       Date:  1979       Impact factor: 12.310

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.